Dana-Farber Cancer Institute

Study IDs benefit of donor SCT for adults with acute myeloid leukemia

Published in Medical Devices and Surgical Technology Week, June 28th, 2009

BOSTON--A stem cell transplant (SCT) from a compatible donor early in the course of disease is the best approach for the majority of young and middle-aged adult patients with acute myeloid leukemia (AML), according to a new analysis of two dozen clinical studies.

The findings of the study, published in the June 10 issue of the Journal of the American Medical Association by researchers at Dana-Farber Cancer Institute and other institutions, provide new guidelines for treatment of the disease. For all AML patients other than the minority with "good-risk" disease, SCT from a compatible donor significantly improves survival, making it the preferred approach, the authors...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week

Source: Medical Devices and Surgical Technology Week (2009-06-28)

More Articles from Medical Devices and Surgical Technology Week

Universite de Montreal Hospital Centre
An innovative surgical technique gives hope to patients suffering from refractory epilepsy
Wiley-Blackwell
Intestinal bacteria associated with nonalcoholic fatty liver disease
Axiom Worldwide
Axiom Worldwide Announces the NEW DRX9000!
Eye Disease
ISTA Pharmaceuticals Announces Positive Results for Phase 2 Study of Low-Dose Bromfenac in Dry Eye Disease
Fatigue
Kessler Foundation Research Center Study Provides Insight into One of the Most Challenging Symptoms Following a Traumatic Brain Injury
Heart Bypass Surgery
Autogenous Infrainguinal Bypass Outcomes Inferior in Hispanics
More from this issue of Medical Devices and Surgical Technology Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry